Traditions of the Kyrgyz people were being formed with the help of economic, trade, domestic and other relations with kindred and other tribes that were closely related to the geography of their ha...

After the coup of 19 March 1953 in the socio-political history of Iran there were fundamental changes: the powers of parliament were limited and the absolute power of Mohammad Reza Shah Pahlavi was...

In the Middle East, Saudi Arabia and the Islamic Republic of Iran are two countries that claim to leadership in the region. With a powerful resources and political potential these countries are the...

Medical Science, Uzbekistan


In Uzbekistan, the 2017-2021 Program for modernization of the emergency medical care system has been approved. It happened in accordance with the decree of President Shavkat Mirziyoyev “On measures aimed at further improvement of the emergency medical care system,” which was published on the website of the National Legislation Database. For the implementation of this program, there will be allocated funds in the amount of $70.6 million. In particular, this year the car park of the emergency medical care system will be updated with 1,200 units of specialized vehicles.


By 2020, the government of Uzbekistan will begin to independently finance the purchase of necessary vaccines. On March 3, the news was announced by Sasha Graumann, the representative of UNICEF in the republic. “By the end of 2019, Uzbekistan's external support for the purchase of vaccines will come to an end. The government is now working together with UNICEF on effective budget planning to achieve sustainable vaccine procurement and immunization for children,” Graumann said.



By the end of 2017, up to 30 large pharmaceutical companies will be commissioned in Uzbekistan. It became possible due to the benefits recently granted to manufacturers of medicines and medical products. According to head of the State Joint Stock Company “Uzfarmsanoat” Mirzanozim Dusmuratov, currently about 140 pharmaceutical enterprises operate in the country, producing more than 2,000 names of various drugs.



This year, Uzbekistan has seen a reduction in prices for socially important drugs produced by local companies. The decline was in the range of 8 to 44 percent, depending on the medication. Head of the Main Directorate for quality control of medical devices and drugs Habibullo Jalilov reported the news on the website of the Ministry of Health. “Recently, cases of violation of rules and regulations in the process of issuing prescriptions have become frequent, as well as the prescription of drugs of foreign manufacturers instead of local products.


In the framework of the state program “Year of healthy mother and child,” Uzbekistan has allocated $80 million in the forms of loans and grants on equipment of medical institutions of the republic with modern medical and diagnostic equipment. President Shavkat Mirziyoyev said, “In the course of the program, about nine million women of childbearing age, and almost ten million children underwent medical examination. Steps have been taken towards their health improvement.”



Currently, the pharmaceutical industry of Uzbekistan includes a total of more than 130 companies that produce more than 2,000 names of various drugs. In Zaamin District of Jizzakh Province, a new production complex “Zomin pharm” will soon begin its work. It will produce drugs based on processing of local raw materials. Plans are also afoot to establish exports of the manufactured products.



On January 1, 2017, Uzbekistan will introduce limitations in relation to markups on the drugs sold in the country; there will also be introduced fixed prices for socially significant medicines. This follows from the text of the resolution “On measures to further improve the provision of the population of Uzbekistan with medical products and drugs,” which was signed by Acting President of the republic Shavkat Mirziyoyev on November 1.


From November 1, Uzbek health care professionals will benefit from the newly-enforced regulations regarding the new size of surcharges to official salaries paid to certain categories of medical employees in connection with particularly difficult, dangerous or harmful working conditions. In addition, the republic is also introducing new level of wages. According to the local media, the highest premiums in the amount of 75 percent will be given to pathologists.


Over the last ten years, the pharmaceutical industry of Uzbekistan has received more than $300 million in investments, of which about $100 million are foreign direct investments. In addition, the share of foreign partners of the Uzbek pharmaceutical enterprises is 35.7 percent, while the remaining 64.3 percent are owned by local market participants. According to the industry representatives, all this has played a significant role in expanding the range and volume of drug production in the country.



In several provinces of Uzbekistan, there have opened social pharmacies, as reported at the official website of the Ministry of Health. All of them will be part of the country's largest wholesale and retail company “Dori-Darmon” with a state-owned share. The company has invested its own funds in creation of the new health infrastructure facilities, informing that the event is held as part of the celebration of the 25th anniversary of Uzbekistan's independence.